Drug Profile
Research programme: discovery therapeutics - Ossianix
Alternative Names: OSX500; OSX600; OSX700Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Ossianix
- Class
- Mechanism of Action G protein-coupled receptor antagonists; Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Unspecified in USA
- 19 Jul 2016 Early research in Undefined indication in USA (unspecified route)